|
|
||||||||||||||
|
|
|||||||||||||||
EDITORIAL |
| Genetic engineering |
Chairman of the Molecular Immunology Programme at the Babraham Institute; Fellow of St Edmunds College, Cambridge; and Editor of the journal Science and Christian Belief
Correspondence to:
Correspondence to:
Dr Denis Alexander, Molecular Immunology Programme, Babraham Institute, Babraham, Cambridge CB2 4AT, UK;
denis.alexander@bbsrc.ac.uk
Keywords: genetic engineering
| The first 150 words of the full text of this article appear below. |
Genetic engineering refers to the techniques whereby recombinant DNA, hybrid DNA made by artificially joining pieces of DNA from different sources, is produced and utilised. The term has gradually broadened out from this earlier more stringent definition to encompass virtually any process involving DNA manipulation. The applications of genetic engineering are now so widespread and well established within the biomedical sciences that it is difficult for younger investigators to envisage what research life was like in the era before genetic engineering. A quick skim of the articles in the current issue of the Journal of Immunology, a journal that ranges from clinical perspectives to molecular characterisation, reveals that out of 79 articles no less than 65 (82%) utilised genetic engineering as an important component of their investigation. In the more molecular journals that figure would certainly be 100% and even in the most clinical journals genetic engineering
This article has been cited by other articles:
![]() |
K.R. MERIKANGAS Implications of Genomics for Public Health: The Role of Genetic Epidemiology Cold Spring Harb Symp Quant Biol, January 1, 2003; 68(0): 359 - 364. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |